WANG SHAOMENG enters ASCENTAGE PHARMA GROUP INTERNATIONAL with 10.05M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 3/23/2026ACC: 0001213900-26-033127
Director
Since Mar 2026
10.05M
Baseline shares
12% direct
1.19M
Direct ownership
1 position
45.93K
Derivative underlying
2 instruments
3
Security positions
8.86M indirect
Non-Derivative Holdings3
Ordinary Shares
IndirectShares owned6.02M
Ordinary Shares
IndirectShares owned2.84M
Ordinary Shares
DirectShares owned1.19M
Total
1.19M direct·8.86M indirect10.05M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 6.02M | Indirect |
| Ordinary Shares | 2.84M | Indirect |
| Ordinary Shares | 1.19M | Direct |
| Total | 10.05M | 1.19M direct·8.86M indirect |
Derivative Holdings2
Options
DirectUnderlying security
Ordinary Shares
Underlying shares
17.96K
Shares owned
N/A
Exercise price
8.14
Expiration
—
Exercise window
—
Restricted share units
DirectUnderlying security
Ordinary Shares
Underlying shares
27.96K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Total
Underlying
45.93K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options Direct | Ordinary Shares | 8.14 | — | — | 17.96K | N/A |
| Restricted share units Direct | Ordinary Shares | 0 | — | — | 27.96K | N/A |
| Total | 45.93K | 0.00 | ||||